Hepatitis C virus (HCV) infection is associated with gut dysbiosis, and the microbiome transition could be a biological indicator of chronic hepatitis C progression in patients with mild liver disease, according to a study published in Clinical Infectious Diseases.
The gut microbiota is closely associated with the progression of liver diseases, and previous studies indicate that gut dysbiosis affects chronic liver disease, including the most severe forms
Friday, May 25, 2018
News Recap:
In Brief:
Liver Stiffness Measurement as a Potential Screening Tool for Liver-Related Events in HCV. The rate of advanced liver fibrosis in community as opposed to urban settings appears to be significant (16.5%) and often underdiagnosed; therefore, liver stiffness measurement is a feasible community screening tool that can be used to predict liver-related events, according to a study published in the Journal of He...
The rate of advanced liver fibrosis in the community appears to be significant (16.5%) and often underdiagnosed; therefore, liver stiffness measurement is a feasible community screening tool that can be used to predict liver-related events, according to a study published in the Journal of Hepatology.
Chronic hepatitis C is a major health issue that is responsible for more than 1.34 million deaths worldwide annually. Although early identification is associ
CHICAGO, May 22, 2018 /PRNewswire-USNewswire/ -- In a 10 year span, more than 130,000 patients were notified of medical errors that may have exposed them to blood-borne illness, including Hepatitis C. However, the majority of these notification events were discovered only after patients became acutely ill rather than through proactive reporting of violations of health safety protocols, according to a review in The Journal of the American Osteopathic Assoc
Fatty liver disease, diabetes and a triglycerides level of above 160 milligrams per deciliter (mg/dl) are three major risk factors for developing liver cancer, and the disease’s progression does not necessarily include chronic hepatitis or cirrhosis, the National Health Research Institutes (NHRI) said yesterday.
Liver cancer has been the second-leading cause of cancer deaths for many years, and about 85 percent of cases have been associated with chronic h
Friday, May 18, 2018
News Recap:
Canada:
Promoting Drug Pricing Policy Resources for Patient Groups. Patient groups in Canada shared in a recent survey that they struggle to understand the complexities of drug pricing policy in Canada and that they would like more information. In response, the Drug Pricing Policy Summit Working Groups have put together two web pages that outline various resources and learning opportunities to help patient groups lea...
Patient groups in Canada shared in a recent survey that they struggle to understand the complexities of drug pricing policy in Canada and that they would like more information. In response, the Drug Pricing Policy Summit Working Groups have put together two web pages that outline various resources and learning opportunities to help patient groups learn more. Please take a look at what is available and share the links with others who would benefit.
Dru
Patient-reported outcomes such as fatigue, vitality and mental health improve substantially in the two years following hepatitis C cure for people with cirrhosis, but people with cirrhosis are less likely than others to experience rapid resolution of severe fatigue after successful hepatitis C treatment.
Quality of life can be severely impaired in people with chronic hepatitis C, especially in people with cirrhosis. Fatigue, insomnia, problems in physical
Robert Morin remembers the day, 30 years ago, when it hit him: It started with a feeling of pins and needles all over his body and by the end of the day he could barely walk.
Now 52, Morin was a college student at the time. He soon learned he was suffering from a serious liver disease — autoimmune hepatitis — in which his own body was attacking his liver.
The diagnosis was a shock, but the good news was that, with treatment to suppress his immune syste
Infants exposed to hepatitis C virus (HCV) in utero are not being screened, leaving many pediatric infections undetected, according to a new study from researchers at Magee-Womens Research Institute. (However, in Canada, screening of pregnant women was recommended by the Canadian Task Force on Preventive Health Care (CTFPHC) in April 2017).
The rate of HCV infection among pregnant women has increased in recent years, due partly to the opioid epidemic. Th
